98%
921
2 minutes
20
The diagnosis of von Willebrand disease (VWD), the most common inherited bleeding disorder, is characterised by a variable bleeding tendency and heterogeneous laboratory phenotype. The sequencing of the entire VWF coding region has not yet become a routine practice in diagnostic laboratories owing to its high costs. Nevertheless, next-generation sequencing (NGS) has emerged as an alternative to overcome this limitation. We aimed to determine the correlation of genotype and phenotype in 92 Portuguese individuals from 60 unrelated families with VWD; therefore, we directly sequenced VWF. We compared the classical Sanger sequencing approach and NGS to assess the value-added effect on the analysis of the mutation distribution in different types of VWD. Sixty-two different VWF mutations were identified, 27 of which had not been previously described. NGS detected 26 additional mutations, contributing to a broad overview of the mutant alleles present in each VWD type. Twenty-nine probands (48.3 %) had two or more mutations; in addition, mutations with pleiotropic effects were detected, and NGS allowed an appropriate classification for seven of them. Furthermore, the differential diagnosis between VWD 2B and platelet type VWD (n = 1), Bernard-Soulier syndrome and VWD 2B (n = 1), and mild haemophilia A and VWD 2N (n = 2) was possible. NGS provided an efficient laboratory workflow for analysing VWF. These findings in our cohort of Portuguese patients support the proposal that improving VWD diagnosis strategies will enhance clinical and laboratory approaches, allowing to establish the most appropriate treatment for each patient.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1160/TH15-07-0604 | DOI Listing |
Blood
September 2025
INSERM, Le Kremlin Bicêtre, France.
Von Willebrand disease (VWD)-type 1 is a bleeding disorder characterized by a quantitative deficiency of functional von Willebrand factor (VWF). We designed a novel bispecific nanobody, named KB-V13A12, that aims to increase endogenous VWF levels by bridging it to albumin. KB-V13A12 comprises two single-domain antibodies, one targeting VWF and one targeting albumin.
View Article and Find Full Text PDFBlood Adv
September 2025
University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
Postpartum hemorrhage (PPH) affects up to 44% of women with von Willebrand disease (VWD) despite recombinant VWF (rVWF) treatment. As tranexamic acid (TXA) reduced PPH-related deaths in the WOMAN trial, we assessed whether TXA combined with rVWF versus rVWF alone prevents PPH in VWD. VWD-Woman, a phase 3, open-label, randomized pilot trial, enrolled pregnant women ≥18 years with VWD (VWF:RCo <0.
View Article and Find Full Text PDFBMC Oral Health
August 2025
Department of Anatomy, Faculty of Dentistry, Ankara University, Ankara, Turkey.
The objective of the study was to discuss the effect of root canal preparation using files with varying tapers and active cutting parts on stress distribution in mandibular first molars with curved and straight mesial roots via 3-dimensional (3D) finite element analysis (FEA). Mesial root canals of six artificial mandibular molar models were prepared up to ProTaper Universal F2 (size 25/0.08 taper) (Dentsply Sirona Endodontics, Ballaigues, Switzerland), ProTaper Universal F3 (size 30/0.
View Article and Find Full Text PDFBlood Adv
August 2025
Queen's University, Kingston, Ontario, Canada.
von Willebrand disease (VWD) is the most common inherited bleeding disorder, resulting from a deficiency and/or dysfunction of von Willebrand factor (VWF). Since its first description 100 years ago, the diagnosis of VWD has evolved due to advancements in laboratory diagnostic tests and clinical guidelines and recommendations. There are three established diagnostic criteria for VWD: a personal history of excessive mucocutaneous bleeding, a family history of bleeding, and reduced VWF levels.
View Article and Find Full Text PDFJ Gastrointest Surg
August 2025
Department of Surgery, University of Minnesota, Minneapolis, MN, United States.
Background: Hereditary coagulation disorders (HCDs), including hemophilia and von Willebrand disease (VWD), are associated with an increased risk of perioperative bleeding. However, despite advances in medical management, the outcomes after routine procedures, such as laparoscopic cholecystectomy, in this population remain insufficiently characterized. This study aimed to evaluate the outcomes and readmissions of patients with HCDs after laparoscopic cholecystectomy.
View Article and Find Full Text PDF